| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 700.515 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 455.154 | 91 |
| GSM780709 | Untreated after 4 days (C3_1) | 390.547 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 714.104 | 94 |
| GSM780720 | Untreated after 4 days (C2_2) | 472.783 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 388.459 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 475.501 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 531.693 | 92 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 915.483 | 95 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 478.302 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 516.309 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 876.867 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 490.569 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 500.496 | 92 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 546.2 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 560.323 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 574.602 | 92 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 544.606 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 588.096 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 585.106 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 542.959 | 92 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 556.332 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 522.419 | 92 |